Q1 2025 Holdings
Filed 2025-05-14 | 35 holdings | $122.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $12.2M | 368,665 | 10.0% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $9.8M | 514,702 | 8.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $9.5M | 119,196 | 7.7% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $9.4M | 147,990 | 7.7% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $9.2M | 253,675 | 7.5% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $6.6M | 146,765 | 5.4% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $5.9M | 121,400 | 4.8% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $5.7M | 79,650 | 4.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $5.3M | 158,605 | 4.3% |
| Merus N V | COM | N5749R100 | $5.1M | 120,038 | 4.1% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $4.3M | 15,722 | 3.5% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $4.0M | 414,246 | 3.3% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $3.9M | 11,872 | 3.2% |
| Incyte Corp(INCY) | COM | 45337C102 | $3.6M | 59,022 | 2.9% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $3.5M | 664,610 | 2.9% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $3.5M | 227,090 | 2.8% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $2.6M | 49,120 | 2.1% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $2.4M | 64,200 | 1.9% |
| Geron Corp(GERN) | COM | 374163103 | $2.2M | 1,373,550 | 1.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $2.1M | 13,600 | 1.7% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $2.0M | 1,883,179 | 1.7% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.8M | 154,522 | 1.5% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.7M | 102,984 | 1.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $1.7M | 2,800 | 1.4% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $845.0K | 30,875 | 0.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $680.8K | 19,253 | 0.6% |
| Rani Therapeutics Hldgs Inc(RANI) | COM CL A | 753018100 | $621.9K | 493,584 | 0.5% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $585.3K | 68,943 | 0.5% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $565.7K | 463,654 | 0.5% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $466.8K | 1,166,952 | 0.4% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $443.7K | 49,082 | 0.4% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $253.0K | 37,095 | 0.2% |
| Bolt Projs Hldgs Inc | COM | 09769B107 | $249.5K | 811,952 | 0.2% |
| Affimed N V | ORDINARY SHS NEW | N01045207 | $26.9K | 37,247 | 0.0% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $26.1K | 41,950 | 0.0% |